News

The stock market is roaring back in 2023 following a downturn. However, the year hasn't been kind to every company. For instance, drugmakers AbbVie (NYSE: ABBV) and Axsome Therapeutics (NASDAQ:

Want a good dividend stock to own? Don't focus just on the yield itself. When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the

Canadian cannabis company Tilray Brands (NASDAQ: TLRY) has been on the right track ever since it merged with rival Aphria in 2021. From an operational standpoint, it had been consistently

According to a recent Ipsos poll, one in five Americans don't expect to retire, and that's largely because they don't feel they can afford to do so. One way for Americans to improve their financial

What's the single best stock to buy right now? Ask five different investors and you'll probably get five different answers.

The problem, of course, is that defining what makes a given candidate the

AT&T (NYSE: T) pays a high dividend that yields 7.6%. At that level of payout, investors owning a little more than $13,100 in stock would collect $1,000 in annual dividend income. But when it comes

Image source: The Motley Fool.

Sarepta Therapeutics (NASDAQ: SRPT)Q2 2023 Earnings CallAug 02, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Karyopharm Therapeutics (NASDAQ: KPTI)Q2 2023 Earnings CallAug 02, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Blueprint Medicines (NASDAQ: BPMC) were down more than 12% as of 12:45 p.m. on Wednesday after the healthcare company announced second-quarter earnings. The stock is still up more than 27%

Image source: The Motley Fool.

Exelixis (NASDAQ: EXEL)Q2 2023 Earnings CallAug 01, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Pfizer (NYSE: PFE)Q2 2023 Earnings CallAug 01, 2023, 10:00 a.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2023 Earnings CallAug 01, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Merck (NYSE: MRK)Q2 2023 Earnings CallAug 01, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

The stock market has surged this year, and tech stocks have done particularly well. While the S&P 500 is up about 19% year to date, the tech-heavy Nasdaq Composite has soared roughly 37 %.

The

When analyzing a dividend stock, pretty much every piece of advice will tell you to avoid stocks paying higher than a 5% or 6% dividend. This is because the market has dropped the stock's share

Any time is a good time for income investors to buy dividend stocks. But certain times are better than others for specific stocks.

I think that's the case for several great picks with a new month

Biogen's (NASDAQ: BIIB) biggest problem in recent times has been growth. The biotech giant's multiple sclerosis (MS) portfolio is facing more and more generic competition, and that's resulted in

News of a fresh COVID-19 surge sent numerous stockholders into the shares of vaccine maker Novavax (NASDAQ: NVAX) on the first trading day of the week. As a result, Novavax's shares popped more than

Eli Lilly (NYSE: LLY) and Biogen (NASDAQ: BIIB) will soon likely be going head to head in the market for therapies that treat Alzheimer's disease. Both drug developers see the market for such

Shares of Reata Pharmaceuticals (NASDAQ: RETA) recently jumped about 54% higher in a single trading session. This biotech stock was already way up this year thanks to the recent approval of its